Abstract:Aim: To investigate the expression level of plasma vascular endothelial growth factor (P-VEGF) in patients with hepatocellular carcinoma (HCC) and its relationship with the clinicopathologic characteristics, and to examine the changes of P-VEGF in the course of transcatheter arterial chemoembolization (TACE). Methods: Peripheral blood samples were taken from 45 HCC patients before and 1, 3, 7 d, and 1 mo after TACE. Plasma VEGF level was measured with the quantitative sandwich enzyme-linked immunosorbent assay (ELISA). Twenty patients with benign liver lesions and 17 healthy control subjects were also included in this study. Results: Plasma VEGF levels in HCC patients were significantly elevated as compared to those in patients with benign liver lesions (P = 0.006) and in the normal controls (P = 0.003). Significant differences were observed when P-VEGF was categorized by tumor size (P = 0.006), portal vein thrombosis (P = 0.011), distant metastasis (P = 0.017), arterial-portal vein shunting (P = 0.026), and International Union Against Cancer (UICC) TNM stage (P = 0.044). There was no correlation between plasma level of VEGF and the level of alpha fetoprotein (alpha-FP) (r = 0.068, P = 0.658) and weakly correlated with the number of platelets (r = 0.312, P = 0.038). P-VEGF levels increased significantly and reached the peak value on the first day after TACE, and then decreased gradually. The change rate of P-VEGF concentration (one month post-TACE/pre-TACEX100%) was correlated with the retention rate of lipiodol oil (r s = 0.494, P = 0.001) and the tumor volume change (r s = 0.340, P = 0.034). The patients who achieved a partial or complete response to TACE therapy showed significantly less pre-treatment P-VEGF than those nonresponders (P = 0.025). A high pre-therapeutic P-VEGF level was associated with poor response to treatment (P = 0.018). Conclusion: A high pre-treatment P-VEGF level is a useful marker for tumor progression, especially for vascular invasion. TACE increases the level of P-VEGF only temporarily which may be associated with tumor ischemia. P-VEGF may be useful in predicting treatment response, monitoring disease course after TACE and judging the effect of different TACE regimens.

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

Relationship of HDGF or VEGF expression with hepatocellular carcinoma angiogenesis:report of 108 cases

CD36 and Its Role in Regulating the Tumor Microenvironment

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Expression and Clinical Significance of CD146 and VEGF in Hepatocellular Carcinoma

Correlation of MCP-1 Expression with Angiogenesis in Hepatocellular Carcinoma

Expression of HIF-1α and VEGF in Hepatocellular Carcinoma and Correlation with Tumor Angiogenesis

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

Clinical Significance of High Expression of Stanniocalcin-2 in Hepatocellular Carcinoma

Down-expression of CD36 in Pancreatic Adenocarcinoma and Its Correlation with Clinicopathological Features and Prognosis.

RESEACH ON THE RELATIONSHIP BETWEEN CD146,MICROVESSEL DENSITY OF HEPATOCELLULAR CARCINOMA AND ITS CLINIC-PATHOLOGY

Expression of Platelet-Derived Endothelial Cell Growth Factor and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

The Expression and Significance of Tumor Necrosis Factor Receptor 1 in Human Hepatocellular Carcinoma

STUDY ON THE CLINICAL-PATHOLOGICAL SIGNIFICANCE OF MICROVESSEL DENSITY AND VASCULAR ENDOTHILIAL GROWTH FACTOR EXPRESSION IN PRIMARY LIVER CANCER

Expressions and clinical significance of CD146 and MMP-2 in hepatocellular carcinoma

Expression of Survivin and HIF-1α in Hepatocellular Carcinoma and Its Clinical Significance

[Expression of Vascular Endothelial Growth Factor Correlates with Invasion and Metastasis of Hepatocellular Carcinoma].

Expression of TSLC1 protein in human hepatocellular carcinoma and its clinical significance

Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level

Role of TSP-1 As Prognostic Marker in Various Cancers: a Systematic Review and Meta-Analysis

Expression of Caveolin-1 Gene in Hepatitis B-related Hepatocellular Carcinoma and the Clinical Significance Thereof